UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Increased by Procyon Private Wealth Partners LLC

Procyon Private Wealth Partners LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,613 shares of the healthcare conglomerate’s stock after purchasing an additional 129 shares during the quarter. Procyon Private Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,193,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Atom Investors LP bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $1,723,000. GWM Advisors LLC raised its holdings in shares of UnitedHealth Group by 8.3% during the second quarter. GWM Advisors LLC now owns 31,240 shares of the healthcare conglomerate’s stock valued at $12,510,000 after acquiring an additional 2,397 shares during the period. Seven Springs Wealth Group LLC raised its holdings in shares of UnitedHealth Group by 58.6% during the second quarter. Seven Springs Wealth Group LLC now owns 2,544 shares of the healthcare conglomerate’s stock valued at $1,019,000 after acquiring an additional 940 shares during the period. Parametric Portfolio Associates LLC raised its holdings in shares of UnitedHealth Group by 2.2% during the second quarter. Parametric Portfolio Associates LLC now owns 3,874,820 shares of the healthcare conglomerate’s stock valued at $1,551,633,000 after acquiring an additional 81,995 shares during the period. Finally, Welch & Forbes LLC raised its holdings in shares of UnitedHealth Group by 46.2% during the second quarter. Welch & Forbes LLC now owns 4,572 shares of the healthcare conglomerate’s stock valued at $1,831,000 after acquiring an additional 1,445 shares during the period. Institutional investors and hedge funds own 86.20% of the company’s stock.

NYSE UNH opened at $450.16 on Thursday. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59. The company has a fifty day simple moving average of $430.47 and a 200 day simple moving average of $418.01. The company has a market cap of $423.98 billion, a P/E ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a 1 year low of $320.35 and a 1 year high of $466.00.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. UnitedHealth Group’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.51 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be paid a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a yield of 1.29%. The ex-dividend date is Friday, December 3rd. UnitedHealth Group’s payout ratio is currently 35.98%.

In other news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total value of $1,041,875.00. Following the completion of the transaction, the director now owns 154,403 shares in the company, valued at approximately $64,347,450.25. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 82,500 shares of company stock valued at $36,855,125. Corporate insiders own 0.55% of the company’s stock.

A number of equities research analysts have recently issued reports on UNH shares. Mizuho boosted their price target on shares of UnitedHealth Group from $455.00 to $500.00 and gave the company a “buy” rating in a report on Wednesday, November 10th. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $478.00 to $520.00 and gave the company an “overweight” rating in a research report on Monday, October 25th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $421.00 to $477.00 and gave the company a “buy” rating in a research report on Tuesday, November 16th. SVB Leerink started coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They set an “outperform” rating and a $480.00 price objective on the stock. Finally, Royal Bank of Canada boosted their price objective on shares of UnitedHealth Group from $473.00 to $476.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. One equities research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $477.35.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Story: What are the disadvantages of after-hours trading?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.